Qlaris Bio Appoints Parisa Zamiri, M.D., Ph.D., to Board of Directors

Physician-scientist and ophthalmology drug development leader brings deep clinical and regulatory expertise to support Qlaris Bio’s late-stage pipeline DEDHAM, Mass.–(BUSINESS WIRE)–Qlaris Bio, Inc., a clinical-stage biotechnology company focused on developing first-in-class therapies for glaucoma, today announced the appointment of Parisa Zamiri, M.D., Ph.D., to its board of directors. Dr. Zamiri’s appointment comes as Qlaris continues […]